British Heart Foundation: Our research highlights of 2021
From AI technology that can predict heart attacks to a potential new drug for incurable vascular dementia, the BHF has had a great year of scientific discoveries, each bringing us one step closer to making heart and circulatory disease a thing of the past.
Our work has been featured in the BHF research highlights of 2021. To read the full article, visit the BHF article.
Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation
Press Release Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment (LODOCO®– colchicine, 0.5 mg…
American Heart Association Late-Breaking Science Presentation Reveals Majority of Adverse Cardiac Events Occur Among Patients Without Obstructive Coronary Artery Disease but Risks Are Detectable by Novel AI
Press Release Caristo’s AI Technology for Coronary Inflammation Measurement and Risk Assessment Can Transform Risk Stratification and Management of Patients…